Electromed, Inc. (NYSE:ELMD) Director Andrew Summers Sells 17,463 Shares

Electromed, Inc. (NYSE:ELMD) Director Andrew Summers sold 17,463 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $30.09, for a total transaction of $525,461.67. Following the transaction, the director now directly owns 189,838 shares of the company’s stock, valued at approximately $5,712,225.42. This represents a 8.42 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Andrew Summers also recently made the following trade(s):

• On Wednesday, December 4th, Andrew Summers sold 12,731 shares of Electromed stock. The shares were sold at an average price of $29.98, for a total value of $381,675.38.

Electromed Stock Performance

NYSE ELMD opened at $29.82 on Thursday. The stock has a market capitalization of $252.28 million, a PE ratio of 41.82 and a beta of 0.29. The stock has a 50-day simple moving average of $24.92 and a 200 day simple moving average of $18.95. Electromed, Inc. has a twelve month low of $9.81 and a twelve month high of $31.31.

Electromed (NYSE:ELMD) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13. The business had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. State Street Corp grew its position in Electromed by 14.5% during the third quarter. State Street Corp now owns 22,066 shares of the company’s stock worth $474,000 after buying an additional 2,800 shares in the last quarter. Gabelli Funds LLC lifted its position in shares of Electromed by 7.8% in the 2nd quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock worth $581,000 after acquiring an additional 2,808 shares during the period. Pekin Hardy Strauss Inc. grew its holdings in shares of Electromed by 9.9% during the 3rd quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock worth $820,000 after purchasing an additional 3,435 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Electromed by 4.8% during the second quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock valued at $1,548,000 after purchasing an additional 4,736 shares during the period. Finally, Vanguard Group Inc. raised its stake in shares of Electromed by 1.6% in the first quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock valued at $5,929,000 after purchasing an additional 5,886 shares in the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.